CHAMPIONS ONCOLOGY, INC. (CSBR)
Data as of , from SEC Form 4 filings.
See up to 3 months of CSBR. The 7-day demo opens the 1M and 3M ranges and puts CSBR on your watchlist.
Start 7-day demoLatest CSBR insider trades
About CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. is an SEC registrant, filing under CIK 0000771856, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
CSBR Form 4 activity by transaction type, last 90 days
No Form 4 activity for CSBR in the last 90 days.
CSBR insider transactions (Form 4)
2013 Form 4 filings on record, the earliest from Nov 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 9,901 | $10.10 | $100K | |
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 14,130 | $7.00 | $99K | |
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 19,070 | $5.51 | $105K | |
| Robert Lawrence Brainin - Director | Grant or award | Option to purchase Common Stock | 23,030 | $4.64 | $107K | |
| Philip P. Breitfeld - Director | Grant or award | Option to purchase Common Stock | 13,790 | $6.80 | $94K | |
| David Sidransky - Director | Grant or award | Option to purchase Common Stock | 21,216 | $6.80 | $144K | |
| Daniel Newman Mendelson - Director | Grant or award | Option to purchase Common Stock | 13,790 | $6.80 | $94K | |
| Scott R. Tobin - Director | Grant or award | Option to purchase Common Stock | 25,460 | $6.80 | $173K | |
| Joel Ackerman - Director | Grant or award | Option to purchase Common Stock | 21,216 | $6.80 | $144K | |
| Joel Ackerman - Director | Option exercise | Common Stock | 94,405 | $2.10 | $198K | |
| Joel Ackerman - Director | Option exercise | Option to purchase Common Stock | 94,405 | $2.10 | $198K | |
| Philip P. Breitfeld - Director | Grant or award | Option to purchase Common Stock | 18,715 | $4.64 | $87K | |
| Daniel Newman Mendelson - Director | Grant or award | Option to purchase Common Stock | 21,590 | $4.64 | $100K | |
| David Sidransky - Director | Grant or award | Option to purchase Common Stock | 21,880 | $4.64 | $102K | |
| Joel Ackerman - Director | Grant or award | Option to purchase Common Stock | 43,190 | $4.64 | $200K | |
| Scott R. Tobin - Director | Grant or award | Option to purchase Common Stock | 34,550 | $4.64 | $160K | |
| Joel Ackerman - Director | Option exercise | Common Stock | 88,470 | $2.10 | $186K | |
| Joel Ackerman - Director | Option exercise | Common Stock | 16,667 | $5.43 | $91K | |
| Joel Ackerman - Director | Option exercise | Option to purchase Common Stock | 88,470 | $2.10 | $186K | |
| Joel Ackerman - Director | Option exercise | Option to purchase Common Stock | 16,667 | $5.43 | $91K |
CSBR insider trading FAQ
What is the latest insider trade for CSBR?
CHAMPIONS ONCOLOGY, INC. (CSBR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-01-30. The full record for CSBR runs to 13 Form 4 filings, the earliest from 2024-11-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CSBR stock?
No insider purchases of CSBR were filed in the last 90 days.
How many insiders are selling CSBR stock?
No insider sales of CSBR were filed in the last 90 days.
Where can I see CSBR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CSBR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert Lawrence Brainin view on EDGAR
- - Philip P. Breitfeld view on EDGAR
- - David Sidransky view on EDGAR
- - Daniel Newman Mendelson view on EDGAR
- - Scott R. Tobin view on EDGAR
- - Joel Ackerman view on EDGAR
- - Joel Ackerman view on EDGAR
- - Philip P. Breitfeld view on EDGAR
- - Daniel Newman Mendelson view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CSBR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CSBR with a 7-day demo
- CSBR on your watchlist
- Every CSBR Form 4 filing on record
- Up to 3 months of CSBR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
